array(3) { ["company_details"]=> array(13) { ["name"]=> string(27) "Tekla World Healthcare Fund" ["slug"]=> string(36) "b56a5-us-tekla-world-healthcare-fund" ["logo"]=> NULL ["description"]=> string(834) "Tekla World Healthcare Fund is a diversified closed-end fund that primarily invests in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investments in companies engaged in the healthcare industry, including equity securities and debt securities. The fund is traded on the New York Stock Exchange under the ticker THW. As of September 6, 2023, the fund's net asset value (NAV) was $12.25 and the market price was $13.08, representing a premium/discount of 6.78%. The fund has a current distribution rate of 10.52% and paid a monthly dividend per share of $0.1167 on August 31, 2023. Please note that the distribution classifications are preliminary and may be re-classified at year-end. More information about the fund can be found on the Tekla Capital Management LLC website." ["address_street"]=> string(20) "100 Federal St FL 19" ["address_place"]=> string(6) "Boston" ["address_region"]=> string(13) "Massachusetts" ["founding_date"]=> string(10) "2015-01-26" ["website_domain"]=> string(12) "teklacap.com" ["website_url"]=> string(57) "https://www.teklacap.com/funds/thw/info/fund-information/" ["industry_codes"]=> array(1) { [0]=> string(101) "Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices" } ["employee_count"]=> int(3) ["article_count"]=> int(154) } ["articles"]=> array(1) { [0]=> array(7) { ["title_en"]=> string(46) "Tekla World Healthcare Fund - Closed-End Funds" ["snippet_en"]=> string(300) "The Fund seeks current income and long-term capital appreciation. Under normal market conditions, the Fund expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industries including equity securities, convertible securities and debt securities." ["url"]=> string(57) "https://www.cefa.com/FundSelector/FundDetail.fs?ID=212345" ["image_url"]=> NULL ["source"]=> string(8) "cefa.com" ["publication_date"]=> string(10) "2023-03-09" ["categories"]=> array(2) { [0]=> string(5) "Debts" [1]=> string(18) "General Investment" } } } ["category_annotations"]=> array(25) { [0]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(18) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(14) } [2]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(9) } [3]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(5) } [4]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(4) } [5]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(3) } [6]=> array(2) { ["name"]=> string(18) "Business Structure" ["count"]=> int(3) } [7]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(3) } [8]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(3) } [9]=> array(2) { ["name"]=> string(22) "Business Restructuring" ["count"]=> int(2) } [10]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(2) } [11]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(2) } [12]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(2) } [13]=> array(2) { ["name"]=> string(19) "Investment Requests" ["count"]=> int(2) } [14]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(1) } [15]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(1) } [16]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(1) } [17]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(1) } [18]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(1) } [19]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(1) } [20]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(5) "Debts" ["count"]=> int(1) } [22]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(1) } [23]=> array(2) { ["name"]=> string(17) "Commodity Pricing" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(1) } } } b56a5-us-tekla-world-healthcare-fund

Tekla World Healthcare Fund

Location

Massachusetts

Founded

2015-01-26

Website

https://www.teklacap.com/funds/thw/info/fund-information/

Articles

154 Articles

Category

Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices

Description

Tekla World Healthcare Fund is a diversified closed-end fund that primarily invests in the healthcare industry. Its objective is to seek current income and long-term capital appreciation through investments in companies engaged in the healthcare industry, including equity securities and debt securities. The fund is traded on the New York Stock Exchange under the ticker THW. As of September 6, 2023, the fund's net asset value (NAV) was $12.25 and the market price was $13.08, representing a premium/discount of 6.78%. The fund has a current distribution rate of 10.52% and paid a monthly dividend per share of $0.1167 on August 31, 2023. Please note that the distribution classifications are preliminary and may be re-classified at year-end. More information about the fund can be found on the Tekla Capital Management LLC website.

Articles

Tekla World Healthcare Fund - Closed-End Funds

2023-03-09 (cefa.com)

Tekla World Healthcare Fund - Closed-End Funds

The Fund seeks current income and long-term capital appreciation. Under normal market conditions, the Fund expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industries including equity securities, convertible securities and debt securities.

Read more

Newsletter subscription